Relationship between transient DNA hypomethylation and erythroid differentiation of murine erythroleukemia cells. 1988

A Razin, and A Levine, and T Kafri, and S Agostini, and T Gomi, and G L Cantoni
Department of Cellular Biochemistry, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

The state of DNA methylation in mouse erythroleukemia (MEL) cells has been analyzed in relation to commitment to differentiation in response to treatment with hexamethylenebisacetamide (HMBA). Previous experiments have shown that induction by HMBA involves transient genome-wide hypomethylation of DNA that is achieved by replacement of 5-methylcytosine with cytosine residues. The experiments described in the present communication revealed that hypomethylation is a very early event in the process of differentiation. Exposure of the cells to 3-deazaadenosine, an adenosine analog, in combination with homocysteine, resulted in the intracellular accumulation of 3-deazaadenosylhomocysteine, which caused an inhibition of HMBA-induced hypomethylation that was correlated with a comparable inhibition of differentiation. While these experiments suggest that hypomethylation is a necessary step in the process of differentiation, other experiments reported here indicate that hypomethylation of DNA may be necessary but not sufficient to trigger the whole program of differentiation in MEL cells. We found, for example that exposure of the cells to cycloheximide during the first 24 hr of induction by HMBA resulted in complete inhibition of differentiation without significant effect on the HMBA-induced hypomethylation. This result also indicates that the enzymatic machinery required for the hypomethylation of DNA is present in uninduced cells.

UI MeSH Term Description Entries
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008745 Methylation Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed) Methylations
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004915 Leukemia, Erythroblastic, Acute A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. Di Guglielmo's Disease,Erythremic Myelosis,Erythroblastic Leukemia, Acute,Erythroleukemia,Leukemia, Myeloid, Acute, M6,Myeloid Leukemia, Acute, M6,Di Guglielmo Disease,Acute Erythroblastic Leukemia,Acute Erythroblastic Leukemias,Di Guglielmos Disease,Disease, Di Guglielmo,Disease, Di Guglielmo's,Erythremic Myeloses,Erythroblastic Leukemias, Acute,Erythroleukemias,Leukemia, Acute Erythroblastic,Leukemias, Acute Erythroblastic,Myeloses, Erythremic,Myelosis, Erythremic
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.

Related Publications

A Razin, and A Levine, and T Kafri, and S Agostini, and T Gomi, and G L Cantoni
August 1980, The Journal of cell biology,
A Razin, and A Levine, and T Kafri, and S Agostini, and T Gomi, and G L Cantoni
April 1981, Biochimica et biophysica acta,
A Razin, and A Levine, and T Kafri, and S Agostini, and T Gomi, and G L Cantoni
June 1984, Science (New York, N.Y.),
A Razin, and A Levine, and T Kafri, and S Agostini, and T Gomi, and G L Cantoni
March 1978, Cancer research,
A Razin, and A Levine, and T Kafri, and S Agostini, and T Gomi, and G L Cantoni
July 1985, Biochimica et biophysica acta,
A Razin, and A Levine, and T Kafri, and S Agostini, and T Gomi, and G L Cantoni
June 1989, The Journal of biological chemistry,
A Razin, and A Levine, and T Kafri, and S Agostini, and T Gomi, and G L Cantoni
October 1979, Cancer research,
A Razin, and A Levine, and T Kafri, and S Agostini, and T Gomi, and G L Cantoni
August 1981, The Journal of cell biology,
A Razin, and A Levine, and T Kafri, and S Agostini, and T Gomi, and G L Cantoni
December 1979, Proceedings of the National Academy of Sciences of the United States of America,
A Razin, and A Levine, and T Kafri, and S Agostini, and T Gomi, and G L Cantoni
January 1977, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!